January 10, 2008 — Fujifilm Medical Systems USA Inc. will phase out the production of medical imaging film products at Fujifilm Manufacturing USA Inc. in Greenwood, S.C., by April 1, 2008, due to declines in medical film use.
Over the past decade, the medical imaging industry has been undergoing a steady transition from the use of medical imaging film including double and single emulsion and dry films, to digital image acquisition and softcopy diagnosis via Picture Archiving and Communications Systems (PACS). Although Fujifilm Greenwood has been producing X-ray film products, the market shift to PACS systems has led to significant declines in the overall sales of medical film. As a result, Fujifilm Corporation has decided to consolidate the production of all medical film to one facility in Japan.
“As is our history with all of our medical imaging products, Fujifilm is committed to the quality and innovation of our extensive medical film lines. The ongoing and stable delivery of film to our medical customers will continue without interruption,” said FUJIFILM Medical Systems USA President and CEO Makoto Kawaguchi.
For more information: www.fujimed.com
March 31, 2026 
